ISO 9001: 2015: CERTIFIED

PUBLIC NOTICE

20^th August, 2026

NOTICE ON THE RECLASSIFICATION OF KETAMINE AND ITS SALTS AS CONTROLLED DRUG

1. The Tanzania Medicines and Medical Devices Authority (TMDA) wishes to inform its esteemed stakeholders specifically healthcare providers that, the Minister of Health has officially approved the Tanzania Medicines and Medical Devices (Scheduling of Medicines) Regulations, 2026, GN. No. 150.
2. These new Regulations replaces the previous edition of the same Regulations with GN. No. 63. The new Regulations have consequently recategorized Ketamine from a prescription only medicine (POM) to a controlled drug under narcotics classification.
3. Following this new requirement Ketamine containing medicinal products will now be controlled as a narcotic drug.
4. In this respect, all requirements that fall under this classification shall be adhered to including submission of stock and consumption reports as applicable to other narcotic drugs.
5. Importation of Ketamine containing products shall be limited to the Medical Stores Department (MSD) and distributed in authorized premises only.
6. As part of transitioning to this new requirement, health facilities currently holding stocks of Ketamine containing products are directed to submit reports on their stock levels to TMDA HQ or zone offices before 1st of September 2026.
7. After receiving the reports on stock levels, the TMDA will determine the final date of use of Ketamine containing products in private health facilities or other unauthorized supply chain.